Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Single-molecule mitochondrial DNA sequencing shows no evidence of CpG methylation in human cells and tissues

  • Bicci, Iacopo
  • Calabrese, Claudia
  • Golder, Zoe J.
  • Gómez-Durán, Aurora
  • Chinnery, Patrick F.
12 p.-4 fig.-1 tab., Methylation on CpG residues is one of the most important epigenetic modifications of nuclear DNA, regulating gene expression. Methylation of mitochondrial DNA (mtDNA) has been studied using whole genome bisulfite sequencing (WGBS), but recent evidence has uncovered technical issues which introduce a potential bias during methylation quantification. Here, we validate the technical concerns of WGBS, and develop and assess the accuracy of a new protocol for mtDNA nucleotide variant-specific methylation using single-molecule Oxford Nanopore Sequencing (ONS). Our approach circumvents confounders by enriching for full-length molecules over nuclear DNA. Variant calling analysis against showed that 99.5% of homoplasmic mtDNA variants can be reliably identified providing there is adequate sequencing depth. We show that some of the mtDNA methylation signal detected by ONS is due to sequence-specific false positives introduced by the technique. The residual signal was observed across several human primary and cancer cell lines and multiple human tissues, but was always below the error threshold modelled using negative controls. We conclude that there is no evidence for CpG methylation in human mtDNA, thus resolving previous controversies. Additionally, we developed a reliable protocol to study epigenetic modifications of mtDNA at single-molecule and single-base resolution, with potential applications beyond CpG methylation., I.B. is funded by the Cambridge Trust, the MRC-DTP PhD Program and Magdalene College, Cambridge; A.G.D. is an Atracción de Talento M1 Fellow from Comunidad de Madrid (Spain) [2019-T1BMD-14236] who receives support from the Spanish Ministry of Science [PID2020-114709RA-I00]; P.F.C. is a Wellcome Trust Principal Research Fellow [212219/Z/18/Z]; UK NIHR Senior Investigator, who receives support from the Medical Research Council Mitochondrial Biology Unit [MC_UU_00015/9]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease [MR/S005021/1]; Leverhulme Trust [RPG-2018-408]; MRC research grant [MR/S035699/1]; Alzheimer's Society Project Grant [AS-PG-18b-022]; NIHR Cambridge Biomedical Research Centre [BRC-1215-20014].Funding for open access charge: Wellcome Trust., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

p38 MAPK priming boosts VSMC proliferation and arteriogenesis by promoting PGC1α‑dependent mitochondrial dynamics

  • Sahún-Español, Álvaro
  • Clemente, Cristina
  • Jiménez-Loygorri, Juan Ignacio
  • Sierra-Filardi, Elena
  • Herrera-Melle, Leticia
  • Gómez-Durán, Aurora
  • Sabio, Guadalupe
  • Monsalve, María
  • Boya, Patricia
  • Arroyo, Alicia G.
17 p.-6 fig., Vascular smooth muscle cell (VSMC) proliferation is essential for arteriogenesis to restore blood flow after artery occlusion, but the mechanisms underlying this response remain unclear. Based on our previous findings showing increased VSMC proliferation in the neonatal aorta of mice lacking the protease MT4-MMP, we aimed at discovering new players in this process. We demonstrate that MT4-MMP absence boosted VSMC proliferation in vitro in response to PDGF-BB in a cell-autonomous manner through enhanced p38 MAPK activity. Increased phospho-p38 in basal MT4-MMP-null VSMCs augmented the rate of mitochondrial degradation by promoting mitochondrial morphological changes through the co-activator PGC1α as demonstrated in PGC1α−/− VSMCs. We tested the in vivo implications of this pathway in a novel conditional mouse line for selective MT4-MMP deletion in VSMCs and in mice pre-treated with the p38 MAPK activator anisomycin. Priming of p38 MAPK activity in vivo by the absence of the protease MT4-MMP or by anisomycin treatment led to enhanced arteriogenesis and improved flow recovery after femoral artery occlusion. These findings may open new therapeutic opportunities for peripheral vascular diseases., Funding was provided by the Spanish Ministerio de Ciencia e Innovación (AEI/FEDER, UE), SAF2017-83229-R and PID2020-112981RB-I00 (AGA), PID2020-114709RA-I00 (AGD), PID2019-104399RB-I00 (GS), RTI2018-093864-B-I00 (MM), PGC2018-098557-B-I00 (PB), PRE2019-088222 (JIJL) and the Spanish Ministerio de Educación, Cultura y Deporte, FPU15-05802 (LHM). ASE was supported by fellowships from Obra Social La Caixa, Ford-Apadrina La Ciencia and La Residencia de Estudiantes. AGD is an Atracción de Talento M1 Fellow from Comunidad de Madrid (Spain) [2019-T1BMD-14236]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitophagy curtails cytosolic mtDNAdependent activation of cGAS/STING inflammation during aging

  • Jiménez-Loygorri, Juan Ignacio
  • Villarejo-Zori, Beatriz
  • Viedma-Poyatos, Álvaro
  • Zapata-Muñoz, Juan
  • Benítez-Fernández, Rocío
  • Frutos-Lisón, M.D.
  • Tomás Barberán, Francisco
  • Espín de Gea, Juan Carlos
  • Area-Gomez, Estela
  • Gómez-Durán, Aurora
  • Boya, Patricia
15 p.-8 fig., Macroautophagy decreases with age, and this change is considered a hallmark of the aging process. It remains unknown whether mitophagy, the essential selective autophagic degradation of mitochondria, also decreases with age. In our analysis of mitophagy in multiple organs in the mito-QC reporter mouse, mitophagy is either increased or unchanged in old versus young mice. Transcriptomic analysis shows marked upregulation of the type I interferon response in the retina of old mice, which correlates with increased levels of cytosolic mtDNA and activation of the cGAS/STING pathway. Crucially, these same alterations are replicated in primary human fibroblasts from elderly donors. In old mice, pharmacological induction of mitophagy with urolithin A attenuates cGAS/STING activation and ameliorates deterioration of neurological function. These findings point to mitophagy induction as a strategy to decrease age-associated inflammation and increase healthspan., Research in the P.B. lab is supported by grants 310030_215271 Swiss National Science Foundation (SNSF) and PID2021-126864NB I00 from MCIN, Spain. Research in J.C.E lab is supported by PID2019-103914RB-I00 from MICIN (MCIN/AEI/10.13039/501100011033, Spain, Unión Europea NextGenerationEU/PRTR). Both labs are also supported by CSIC Interdisciplinary Thematic Platform PTI-NEURO-AGING+ of the Spanish National Research Council (CSIC) and funded B.V.Z. Research in the AGD lab is supported by grants PID2020-114709RA-I00 and RYC2020-029291-I from MICIN and IDEAS222813GOME from AECC., Peer reviewed